Abbott beats profit estimates but suspends forecast on coronavirus concerns

Abbott Laboratories beat quarterly profit estimates on Thursday as stay-at-home orders prompted customers to stockpile its nutrition products but the company suspended its full-year forecast due to the coronavirus-led uncertainty.